IN2013MU03646A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03646A
IN2013MU03646A IN3646MU2013A IN2013MU03646A IN 2013MU03646 A IN2013MU03646 A IN 2013MU03646A IN 3646MU2013 A IN3646MU2013 A IN 3646MU2013A IN 2013MU03646 A IN2013MU03646 A IN 2013MU03646A
Authority
IN
India
Prior art keywords
acne
hydrates
stable
treatment
provides
Prior art date
Application number
Other languages
English (en)
Inventor
Amol Mandhare
Nilendusen
Paul B Mcgarty
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Priority to PCT/IB2014/066152 priority Critical patent/WO2015075640A1/fr
Priority to US15/037,822 priority patent/US20160287614A1/en
Priority to IN3646MU2013 priority patent/IN2013MU03646A/en
Publication of IN2013MU03646A publication Critical patent/IN2013MU03646A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
IN3646MU2013 2013-11-20 2014-11-19 IN2013MU03646A (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/IB2014/066152 WO2015075640A1 (fr) 2013-11-20 2014-11-19 Formulation(s) pharmaceutique(s) stable (s) d'antibiotiques de la famille des tétracyclines
US15/037,822 US20160287614A1 (en) 2013-11-20 2014-11-19 Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic
IN3646MU2013 IN2013MU03646A (fr) 2013-11-20 2014-11-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3646MU2013 IN2013MU03646A (fr) 2013-11-20 2014-11-19

Publications (1)

Publication Number Publication Date
IN2013MU03646A true IN2013MU03646A (fr) 2015-07-31

Family

ID=52023578

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3646MU2013 IN2013MU03646A (fr) 2013-11-20 2014-11-19

Country Status (3)

Country Link
US (1) US20160287614A1 (fr)
IN (1) IN2013MU03646A (fr)
WO (1) WO2015075640A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
WO2004037225A2 (fr) 2002-10-25 2004-05-06 Foamix Ltd. Mousse cosmetique et pharmaceutique
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (fr) 2007-12-07 2009-07-23 Foamix Ltd. Vecteurs moussants siliconés à base d'huile et de liquide, et formulations
WO2010125470A2 (fr) 2009-04-28 2010-11-04 Foamix Ltd. Véhicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
CA2769677A1 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes a base d'agents non tensioactifs non polymeres, mousses legeres, et leurs utilisations
CA2769625C (fr) 2009-07-29 2017-04-11 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses legeres, et leurs utilisations
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CN102686205A (zh) 2009-10-02 2012-09-19 弗艾米克斯有限公司 局部四环素组合物
US10512608B2 (en) 2015-02-25 2019-12-24 Sun Pharma Advanced Research Company Ltd. Nanoparticulate composition
SG11201707784XA (en) 2015-03-23 2017-10-30 Biopharmx Inc Pharmaceutical tetracycline composition for dermatological use
WO2018039030A1 (fr) * 2016-08-23 2018-03-01 University Of Maryland, Baltimore Procédés de détection et/ou de prédiction de la dégénérescence maculaire liée à l'âge et/ou de la maladie d'alzheimer
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
TR201910426A2 (tr) * 2019-07-12 2019-08-21 Assos Ilac Kimya Gida Ueruenleri Ueretim Ve Ticaret Anonim Sirketi Topikal akne tedavi̇si̇ i̇çi̇n tetrasi̇kli̇n ve tretinoin i̇çeren stabil formülasyon
CN115554243B (zh) * 2022-11-11 2023-03-03 新基元(北京)医药科技有限公司 一种治疗玫瑰痤疮的米诺环素泡沫剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3219529A (en) 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US3389174A (en) 1962-10-04 1968-06-18 American Cyanamid Co Stable tetracycline solutions
US4376118A (en) 1980-10-06 1983-03-08 Miles Laboratories, Inc. Stable nonaqueous solution of tetracycline salt
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
US20080188446A1 (en) 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
US20080188445A1 (en) 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
WO2009090495A2 (fr) * 2007-12-07 2009-07-23 Foamix Ltd. Vecteurs moussants siliconés à base d'huile et de liquide, et formulations
PT104644B (pt) 2009-06-26 2012-11-06 Hovione Farmaciencia S A Formulação tópica contendo uma tetraciclina e método de tratamento de infecções cutâneas usando a mesma
US8592380B2 (en) * 2010-03-26 2013-11-26 Precision Dermatology, Inc. Aerosol foams comprising clindamycin phosphate
MX354137B (es) * 2011-01-19 2018-02-14 Laboratory Skin Care Inc Composiciones topicas de minociclina y metodos de uso de la misma.

Also Published As

Publication number Publication date
US20160287614A1 (en) 2016-10-06
WO2015075640A1 (fr) 2015-05-28

Similar Documents

Publication Publication Date Title
IN2013MU03646A (fr)
PH12019501321A1 (en) Methods of treating or preventing cholesterol related disorders
PH12015502031B1 (en) Tetrahydropyrrolothiazine compounds
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
EP4230264A3 (fr) Promédicaments de fumarates et leur utilisation pour le traitement de diverses maladies
MX361499B (es) Baricitinib deuterado.
MX2015001246A (es) Ibrutinib deuterado.
PH12015501588A1 (en) Compounds and methods for treating bacterial infections
EP3019166A4 (fr) Combinaison pharmaceutique pour le traitement du mélanome
CL2016001349A1 (es) Uso de derivados de bencimidazol-prolina
WO2014153495A3 (fr) Nouveaux inhibiteurs de stats3
EP3484457A4 (fr) Formule locale pour favoriser la cicatrisation.
MX2015008829A (es) Momelotinib deuterado.
NZ730816A (en) Quinoline carboxamides for use in the treatment of multiple myeloma
IN2013MU03862A (fr)
IN2013MU01985A (fr)
NZ732704A (en) Quinoline carboxamides for use in the treatment of leukemia
EP3054996A4 (fr) Agents osseux thérapeutiques purs
MX2014015199A (es) Formulacion de pexiganan estable.
MX2015012610A (es) Pacritinib deuterizado.
MX2016005160A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MX2016005539A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
NZ719215A (en) Pharmaceutical compositions comprising antibacterial agents
EP3024427A4 (fr) Dérivés de 2,2,6-triméthylcyclohexane-carboxylate
UA91886U (uk) 1-трет-бутокси-3-(2,2,6,6-тетраметил-4-гідроксипіперидино)-2-пропанол